RMD ResMed Inc.

NYSE
$222.00

ResMed Inc. (RMD) is expected to report earnings on October 27, 2026, after the market close. The consensus earnings estimate is $2.72 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +7.2% since its last earnings release on August 6, 2026.

ResMed Beat Expectations
Thursday, August 6, 2026 · 4:05 PM ET
Earnings Date
1st Quarter, Sep 2026
Oct 27
Tuesday · 4:05 PM ET
Earnings Whisper
-
vs $2.72
Rev est $1.41B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $226.33

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About ResMed Inc.

ResMed Inc is a developer, manufacturer and distributor of medical products for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 8 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.